Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
Long-term clinical trials, including one that lasted four years, found no serious safety concerns at these levels.7 Most people tolerate ALA well, but some mild side effects can occur, especially at higher doses: Digestive issues like nausea, bloating, or stomach upset Skin reactions, including rash or itching Low blood sugar, especially when taken with diabetes medications These side effects are usually temporary and mild, but they appear more frequently at doses of 1,200mg/day or higher.3 4 Medication interactions ALA may interact with several medications and should be used with caution in these cases:39 Diabetes medications (e.g., insulin, metformin) ALA can help lower blood glucose, which may enhance the effects of diabetes drugs and increase the risk of hypoglycemia

The substantial involvement of inflammatory mediators and diverse cytokines, including TNF-, IL-1, and IL-6, in the initiation, proliferation, and progression of epithelial ovarian cancer, akin to the observations made in endometriosis (95)
If the solution remains cloudy or has visible particles after 30 minutes of gentle rolling, something may be wrong with the peptide
Long-term safety data is limited for many peptides
Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer